Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Partial rocuronium to reduce high respiratory drive during supported ventilation in ARDS
NL-OMON38185Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of rocuronium in acute respiratory distress syndrome (ARDS), sponsored by Radboud University Medical Center. Primary endpoint: Feasibility of rocuronium titration to target low tidal volume. Started Mar 2014; status: recruiting.
02
Drugs
rocuronium
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NL-OMON38185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38185.